Search Geneontologies

Geneontologies

GO ID Ontology GO Term Term Definition Proteins

GO:0071622

BP

regulation of granulocyte chemotaxis

Any process that modulates the rate, frequency or extent of granulocyte chemotaxis. Granulocyte chemotaxis is the movement of a granulocyte in response to an external stimulus.

CAMK1D

GO:0071624

BP

positive regulation of granulocyte chemotaxis

Any process that increases the rate, frequency or extent of granulocyte chemotaxis. Granulocyte chemotaxis is the movement of a granulocyte in response to an external stimulus.

S100A7

GO:0071625

BP

vocalization behavior

The behavior in which an organism produces sounds by a mechanism involving its respiratory system.

SRPX2, DLG4, NLGN4X, NRXN1

GO:0071629

BP

cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process

The chemical reactions and pathways resulting in the breakdown of misfolded proteins in the cytoplasm, which are targeted to cytoplasmic proteasomes for degradation.

RNF126

GO:0071636

BP

positive regulation of transforming growth factor beta production

Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta.

CD46, PTGS2

GO:0071638

BP

negative regulation of monocyte chemotactic protein-1 production

Any process that stops, prevents, or reduces the frequency, rate, or extent of production of monocyte chemotactic protein-1.

SOCS5, APOD, GSTP1, NR1H4, C1QTNF3

GO:0071639

BP

positive regulation of monocyte chemotactic protein-1 production

Any process that activates or increases the frequency, rate, or extent of production of monocyte chemotactic protein-1.

IL1A, IL1B, TWIST1, ADIPOQ, TRPV4

GO:0071642

BP

positive regulation of macrophage inflammatory protein 1 alpha production

Any process that activates or increases the frequency, rate, or extent of production of macrophage inflammatory protein 1 alpha.

TRPV4

GO:0071650

BP

negative regulation of chemokine (C-C motif) ligand 5 production

Any process that stops, prevents, or reduces the frequency, rate, or extent of production of chemokine (C-C motif) ligand 5.

IL10

GO:0071651

BP

positive regulation of chemokine (C-C motif) ligand 5 production

Any process that activates or increases the frequency, rate, or extent of production of chemokine (C-C motif) ligand 5.

DDX3X, MAVS, TRPV4

GO:0071660

BP

positive regulation of IP-10 production

Any process that activates or increases the frequency, rate, or extent of production of IP-10.

MAVS

GO:0071663

BP

positive regulation of granzyme B production

Any process that activates or increases the frequency, rate, or extent of production of granzyme B.

CD244

GO:0071670

BP

smooth muscle cell chemotaxis

The directed movement of a smooth muscle cell in response to an external stimulus.

PDGFRB, PARVA

GO:0071672

BP

negative regulation of smooth muscle cell chemotaxis

Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell chemotaxis.

SLIT2, GSTP1, CORO1B

GO:0071673

BP

positive regulation of smooth muscle cell chemotaxis

Any process that activates or increases the frequency, rate, or extent of smooth muscle cell chemotaxis.

PDGFD

GO:0071674

BP

mononuclear cell migration

The movement of a mononuclear cell within or between different tissues and organs of the body.

LGALS3

GO:0071676

BP

negative regulation of mononuclear cell migration

Any process that decreases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.

SLIT2

GO:0071677

BP

positive regulation of mononuclear cell migration

Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.

TGFB1, TNF, LGALS3

GO:0071679

BP

commissural neuron axon guidance

The process in which the migration of an axon growth cone of a commissural neuron is directed to its target in the brain in response to a combination of attractive and repulsive cues.

NFIB, NRP1, VEGFA, EPHB2, DAG1

GO:0071681

BP

cellular response to indole-3-methanol

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an indole-3-methanol stimulus.

JUP, CTNNA1, CTNNB1, BRCA1

GO:0071691

BP

cardiac muscle thin filament assembly

The aggregation, arrangement and bonding together of proteins to form the actin-based thin filaments of myofibrils in cardiac muscle.

NEBL

GO:0071701

BP

regulation of MAPK export from nucleus

Any process that modulates the frequency, rate or extent of the directed movement of a MAP kinase from the nucleus to the cytoplasm.

DNAJC27

GO:0071709

BP

membrane assembly

The aggregation, arrangement and bonding together of a set of components to form a membrane.

SPTBN1, ANK3

GO:0071711

BP

basement membrane organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the basement membrane.

FLRT2, SPINT2, NID1, MMP11, NID2, DAG1

GO:0071712

BP

ER-associated misfolded protein catabolic process

The chemical reactions and pathways resulting in the breakdown of misfolded proteins transported from the endoplasmic reticulum and targeted to cytoplasmic proteasomes for degradation.

TOR1A, VCP, UFD1L, SDF2, UGGT1, POMT1

GO:0071726

BP

cellular response to diacyl bacterial lipopeptide

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a diacylated bacterial lipopeptide stimulus.

TLR2, CD14, CD36

GO:0071727

BP

cellular response to triacyl bacterial lipopeptide

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a triacylated bacterial lipopeptide stimulus.

TLR2, CD14, TLR1

GO:0071732

BP

cellular response to nitric oxide

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.

AIFM1, CCNA2, CDK2, MT3, FOXO1, HNRNPD, MTR

GO:0071733

BP

transcriptional activation by promoter-enhancer looping

The formation and maintenance of DNA loops that juxtapose the promoter and enhancer regions of RNA polymerase II-transcribed genes and activate transcription from an RNA polymerase II promoter.

RUVBL2

GO:0071763

BP

nuclear membrane organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nuclear inner or outer membrane.

TOR1A, TMEM43

GO:0071765

BP

nuclear inner membrane organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nuclear inner membrane.

TARDBP

GO:0071773

BP

cellular response to BMP stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.

SMAD9, SPINT2, BMP2, BMP4, BMP6, ACVR2A, BMPR1A, DLX5, ADAMTS12, ACVR1, SMAD4, BMPR2, RUNX2, SFRP1, GATA6, HEYL, ADAMTS7

GO:0071774

BP

response to fibroblast growth factor

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fibroblast growth factor stimulus.

PTH, ELK1, TNC, IER2

GO:0071786

BP

endoplasmic reticulum tubular network organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the endoplasmic reticulum (ER) tubular network. The ER tubular network is the ER part that that has membranes with high curvature in cross-section.

TMEM170A, LNP, REEP1, RTN4

GO:0071787

BP

endoplasmic reticulum tubular network assembly

The aggregation, arrangement and bonding together of a set of components to form the endoplasmic reticulum (ER) tubular network. The ER tubular network is the ER part that comprises the membranes with high curvature in cross-section.

ARL6IP1, RTN4

GO:0071799

BP

cellular response to prostaglandin D stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin D stimulus.

TNC, AKR1C3, PTGFR, AKR1C2, PTGDR

GO:0071800

BP

podosome assembly

The aggregation, arrangement and bonding together of a set of components to form a podosome, an actin-rich adhesion structure characterized by formation upon cell substrate contact and localization at the substrate-attached part of the cell.

SH3PXD2B, FARP2, BIN2

GO:0071803

BP

positive regulation of podosome assembly

Any process that activates or increases the rate or extent of podosome assembly.

TNF, LCP1, MAPK9, ARHGEF5, FSCN1

GO:0071805

BP

potassium ion transmembrane transport

A process in which a potassium ion is transported from one side of a membrane to the other.

KCNK1, KCNK3, CNGA1, FXYD4, KCNA1, KCNMA1, KCNH2, PKD2, KCNC3, KCNJ11, KCNG3, KCNV2, KCNE4, SLC9A6, KCNK17, KCNK12, KCNIP2, TMEM38B, SLC9A2, KCNG1, KCNK6

GO:0071806

BP

protein transmembrane transport

The directed movement of a protein across a membrane by means of some agent such as a transporter or pore.

AZGP1, SEC61G, NUTF2, MCL1

GO:0071812

BP

positive regulation of fever generation by positive regulation of prostaglandin secretion

Any process that increases the rate or extent of fever generation via positive regulation of the frequency, rate or extent of the regulated release of a prostaglandin from a cell.

TNFSF11, TNFRSF11A

GO:0071816

BP

tail-anchored membrane protein insertion into ER membrane

A process of protein insertion into the endoplasmic reticulum (ER) membrane in which a tail-anchored (TA) transmembrane protein is incorporated into an endoplasmic reticulum (ER) membrane. TA transmembrane protein, also named type II transmembrane proteins, contain a single C- terminal transmembrane region.

WRB

GO:0071838

BP

cell proliferation in bone marrow

The multiplication or reproduction of cells, resulting in the expansion of a cell population in the bone marrow.

ACE

GO:0071847

BP

TNFSF11-mediated signaling pathway

A series of molecular signals initiated by the binding of tumor necrosis factor ligand superfamily member 11 (TNFSF11) to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

TNFSF11, TNFRSF11A

GO:0071848

BP

positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling

Any TNFSF11-mediated signaling process that increases the rate, frequency, or extent of the ERK1 and ERK2 cascade.

TNFSF11, TNFRSF11A

GO:0071850

BP

mitotic cell cycle arrest

The process in which the mitotic cell cycle is halted during one of the normal phases (G1, S, G2, M).

GADD45A, DUSP1, CDKN1A, CDKN1B, MAGI2, MCPH1, GADD45GIP1, PNPT1, RGCC, CDC14A

GO:0071864

BP

positive regulation of cell proliferation in bone marrow

A process that activates or increases the frequency, rate or extent of cell proliferation in the bone marrow.

PTH, IL6, MEF2C

GO:0071866

BP

negative regulation of apoptotic process in bone marrow

Any process that stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.

PTH, HSPD1

GO:0071870

BP

cellular response to catecholamine stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] and derivatives formed by substitution.

GNB1, NR4A3

GO:0071871

BP

response to epinephrine

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.

PENK, PPARGC1A

GO:0071872

BP

cellular response to epinephrine stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.

PRKACA, SRD5A1, ATP2B4, SNCA, STAR, PDE4D, ADIPOQ, SIRT2, RYR2

GO:0071873

BP

response to norepinephrine

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system.

PPARGC1A

GO:0071874

BP

cellular response to norepinephrine stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system.

APP

GO:0071875

BP

adrenergic receptor signaling pathway

A series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.

PDE4D, AKAP13

GO:0071877

BP

regulation of adrenergic receptor signaling pathway

Any process that modulates the frequency, rate or extent of an adrenergic receptor signaling pathway activity. An adrenergic receptor signaling pathway is the series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.

RGS2

GO:0071879

BP

positive regulation of adrenergic receptor signaling pathway

Any process that activates or increases the frequency, rate or extent of the adrenergic receptor protein signaling pathway. An adrenergic receptor signaling pathway is the series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.

ARRDC3

GO:0071880

BP

adenylate cyclase-activating adrenergic receptor signaling pathway

The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).

ADCY9, ADRB2, ADRB1, ADRB3, ADRA2B, ADRA1D, ADRA1A, ADRA1B

GO:0071883

BP

activation of MAPK activity by adrenergic receptor signaling pathway

The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, followed by the activation of a MAP kinase.

ADRA2B, AKAP13

GO:0071888

BP

macrophage apoptotic process

Any apoptotic process in a macrophage, a mononuclear phagocyte present in a variety of tissues.

CTSL

GO:0071893

BP

BMP signaling pathway involved in nephric duct formation

A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to nephric duct formation.

BMP4

GO:0071894

BP

histone H2B conserved C-terminal lysine ubiquitination

A histone ubiquitination process in which a ubiquitin monomer is added to a conserved lysine residue in the C-terminus of histone H2B. The conserved lysine residue is K119 in fission yeast, K123 in budding yeast, or K120 in mammals.

WAC

GO:0071895

BP

odontoblast differentiation

The process in which a relatively unspecialized cell of neural crest origin acquires the specialized features of an odontoblast, a cell on the outer surface of the dental pulp whose biological function is the creation of dentin.

FAM20C

GO:0071896

BP

protein localization to adherens junction

Any process in which a protein is transported to, and/or maintained at the adherens junction.

DSP, DLG5

GO:0071897

BP

DNA biosynthetic process

The cellular DNA metabolic process resulting in the formation of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one.

TK2, POLQ, TK1, TYMS, LIG1, CTGF, PHB, CENPF, POLG, POLA2, PAPD5, MYBBP1A, POLE4, POLE3, CHRAC1

GO:0071899

BP

negative regulation of estrogen receptor binding

Any process that stops, prevents, or reduces the frequency, rate or extent of estrogen receptor binding, interacting selectively with an estrogen receptor.

RUVBL2

GO:0071901

BP

negative regulation of protein serine/threonine kinase activity

Any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity.

LRP5, H2AFY, LRP6, HSPB1, SFN, CDKN2B, CDKN2C, CDKN1C, CIB1, WNK1, PYCARD

GO:0071902

BP

positive regulation of protein serine/threonine kinase activity

Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity.

SPRY2, IGF2, CSF1R, HSP90AB1, RALB, ACSL1, MAP2K2, SNCA, RHOA, CALM2, MAP2K1, STK4, CAMK1, STK11, EZH2, SLC27A1, ALS2, CIB1, PDCD10, CAB39

GO:0071907

BP

determination of digestive tract left/right asymmetry

Determination of the asymmetric location of various parts of the digestive tract with respect to the left and right halves of the organism. The digestive tract is the anatomical structure through which food passes and is processed.

CCDC103

GO:0071908

BP

determination of intestine left/right asymmetry

Determination of the asymmetric location of the intestine loops with respect to the left and right halves of the organism.

NPHP3

GO:0071909

BP

determination of stomach left/right asymmetry

Determination of the asymmetric location of the stomach with respect to the left and right halves of the organism.

NPHP3

GO:0071910

BP

determination of liver left/right asymmetry

Determination of the asymmetric location of the liver with respect to the left and right halves of the organism.

PKD2, NPHP3

GO:0071918

BP

urea transmembrane transport

The process in which urea, the water-soluble compound H2N-CO-NH2, is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.

AQP9, SLC14A1, AQP3

GO:0071922

BP

regulation of cohesin loading

Any process that modulates the frequency, rate or extent of a process in which a cohesin complex is transported to, or maintained at, a part of a chromosome that is organized into chromatin.

RB1, WAPL, CDCA5, HDAC8

GO:0071930

BP

negative regulation of transcription involved in G1/S transition of mitotic cell cycle

Any process that stop, prevents or decreases transcription as part of the G1/S transition of the mitotic cell cycle.

RB1, E2F1

GO:0071931

BP

positive regulation of transcription involved in G1/S transition of mitotic cell cycle

Any process that activates or increases transcription as part of the G1/S transition of the mitotic cell cycle.

ZPR1, ID2

GO:0071934

BP

thiamine transmembrane transport

The directed movement of thiamine across a membrane into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Thiamine is vitamin B1, a water soluble vitamin present in fresh vegetables and meats, especially liver.

SLC19A2

GO:0071947

BP

protein deubiquitination involved in ubiquitin-dependent protein catabolic process

The removal of one or more ubiquitin groups from a protein as part of a process of ubiquitin-dependent protein catabolism.

TNFAIP3, OTUD7B, ZRANB1

GO:0071951

BP

conversion of methionyl-tRNA to N-formyl-methionyl-tRNA

The modification process that results in the conversion of methionine charged on a tRNA(fMet) to N-formyl-methionine-tRNA(fMet).

MTFMT

GO:0071954

BP

chemokine (C-C motif) ligand 11 production

The appearance of chemokine (C-C motif) ligand 11 (CCL11, also known as eotaxin-1) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.

TNFSF4

GO:0071955

BP

recycling endosome to Golgi transport

The directed movement of substances from recycling endosomes to the Golgi.

TBC1D14

GO:0071962

BP

mitotic sister chromatid cohesion, centromeric

The cell cycle process in which centromeres of sister chromatids are joined during mitosis.

NAA50

GO:0071973

BP

bacterial-type flagellum-dependent cell motility

Cell motility due to the motion of one or more bacterial-type flagella. A bacterial-type flagellum is a motor complex composed of an extracellular helical protein filament coupled to a rotary motor embedded in the cell envelope.

DRC1, DNAAF2

GO:0071976

BP

cell gliding

Cell motility that results in the smooth movement of a cell along a solid surface.

MYO1G

GO:0071985

BP

multivesicular body sorting pathway

A vesicle-mediated transport process in which transmembrane proteins are ubiquitylated to facilitate their entry into luminal vesicles of multivesicular bodies (MVBs); upon subsequent fusion of MVBs with lysosomes or vacuoles, the cargo proteins are degraded.

RAB27B, RAB27A, EXPH5, SYTL4, VTA1

GO:0072001

BP

renal system development

The process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure. The renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels.

BMP4, ITGB4, ITGA6, EMX2, PTCH1, NUP93, SOX17, SEC63

GO:0072006

BP

nephron development

The process whose specific outcome is the progression of the nephron over time, from its formation to the mature structure. A nephron is the functional unit of the kidney.

ITGA3, JAG1

GO:0072011

BP

glomerular endothelium development

The process whose specific outcome is the progression of the glomerular endothelium over time, from its formation to the mature structure. The glomerular endothelium is an epithelial tissue that covers the internal surfaces of the glomerulus.

PECAM1

GO:0072012

BP

glomerulus vasculature development

The biological process whose specific outcome is the progression of a glomerulus vasculature from an initial condition to its mature state. This process begins with the formation of the glomerulus vasculature and ends with the mature structure. The glomerulus vasculature is composed of the tubule structures that carry blood or lymph in the glomerulus.

ANGPT2, HES1, ANGPT1

GO:0072014

BP

proximal tubule development

The process whose specific outcome is the progression of the proximal tubule over time, from its formation to the mature structure. In mammals, the proximal tubule is a nephron tubule that connects Bowman's capsule to the descending thin limb of the loop of Henle. It has a brush border epithelial morphology.

HEYL

GO:0072015

BP

glomerular visceral epithelial cell development

The process whose specific outcome is the progression of a glomerular visceral epithelial cell over time, from its formation to the mature structure. A glomerular visceral epithelial cell is a specialized epithelial cell that contains feet that interdigitate with the feet of other glomerular epithelial cells.

BMP4, IQGAP1, JAG1, MYO1E, MAGI2, NUP93

GO:0072017

BP

distal tubule development

The process whose specific outcome is the progression of the distal tubule over time, from its formation to the mature structure. In mammals, the distal tubule is a nephron tubule that begins at the macula densa and extends to the connecting tubule.

NOTCH1, JAG1

GO:0072033

BP

renal vesicle formation

The developmental process pertaining to the initial formation of the renal vesicle from condensed mesenchymal cells. The renal vesicle is the primordial structure of the nephron epithelium, and is formed by the condensation of mesenchymal cells.

CTNNB1

GO:0072034

BP

renal vesicle induction

Signaling at short range between cells of the ureteric bud terminus and the kidney mesenchyme that positively regulates the formation of the renal vesicle.

SOX9, SOX8

GO:0072044

BP

collecting duct development

The process whose specific outcome is the progression of a collecting duct over time, from its formation to the mature structure. The collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance. It is the final common path through which urine flows before entering the ureter and then emptying into the bladder.

NOTCH1

GO:0072049

BP

comma-shaped body morphogenesis

The process in which the comma-shaped body is generated and organized. The comma-shaped body is the precursor structure to the S-shaped body that contributes to the morphogenesis of the nephron.

HES1

GO:0072050

BP

S-shaped body morphogenesis

The process in which the S-shaped body is generated and organized. The S-shaped body is the successor of the comma-shaped body that contributes to the morphogenesis of the nephron.

HES1

GO:0072053

BP

renal inner medulla development

The process whose specific outcome is the progression of the renal inner medulla over time, from its formation to the mature structure. The renal inner medulla is unique to mammalian kidneys and is the innermost region of the mammalian kidney.

CTNNB1

GO:0072054

BP

renal outer medulla development

The process whose specific outcome is the progression of the renal outer medulla over time, from its formation to the mature structure. The renal outer medulla is the region of the kidney that lies between the renal cortex and the renal inner medulla.

CTNNB1

GO:0072061

BP

inner medullary collecting duct development

The process whose specific outcome is the progression of the inner medullary collecting duct over time, from its formation to the mature structure. The inner medullary collecting duct is the portion of the collecting duct that lies in the renal inner medulla.

AKR1B1

GO:0072070

BP

loop of Henle development

The process whose specific outcome is the progression of the loop of Henle over time, from its formation to the mature structure. The loop of Henle is a nephron tubule that connects the proximal convoluted tubule to the distal convoluted tubule.

JAG1